Researchers discover a blood biomarker which could predict severe cognitive decline in patients with Parkinson's disease.
A new study reports researchers have successfully created a human stem cell model of Parkinson's disease in a dish.
According to a new study, a protein called Tet3FL removes methyl groups from specific genes, keeping them active.
Mutations of the GBA gene, a known risk factor for Parkinson's disease, appear to also influence the development of cognitive decline, a new study reports.
Researchers report the accumulation of glycosphingolipids in the substantia nigra appears to be elevated in Parkinson's disease patients. The finding could be used as a biomarker for helping diagnose Parkinson's before symptoms of the disease set in.
Increased ceramide levels in the brain may be a unique feature of all types of Lewy body dementias, including LBD associated with Parkinson's disease.
